| Dr Jessica Jewel Maxine Telleria, MD | |
|
2740 South Ave W Ste 101, Missoula, MT 59804-5137 | |
| (406) 728-6101 | |
| (406) 721-3278 |
| Full Name | Dr Jessica Jewel Maxine Telleria |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 13 Years |
| Location | 2740 South Ave W Ste 101, Missoula, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770882565 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 57549 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Medical Center | Missoula, MT | Hospital |
| St. Patrick Hospital | Missoula, MT | Hospital |
| Marcus Daly Memorial Hospital - Cah | Hamilton, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Rockies Orthopaedics, Pllp | 6507766227 | 24 |
News Archive
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
The current study found that people were at a slightly higher than normal risk of blood clots after receiving Oxford-AstraZeneca and Pfizer vaccines.
The United Nations Foundation (UN Foundation) announced today that it has received a US$139 million contribution from the GAVI Alliance to support the worldwide effort by the Measles Initiative to reduce measles deaths by 90 percent by 2010.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
Kaiser Health News staff writer Julie Appleby reports on confusion about how the new health law affects college health plans. "Colleges and universities say some rules in the new health law could keep them from offering low-cost, limited benefit student insurance policies
› Verified 8 days ago
| Entity Name | Northern Rockies Orthopaedics, Pllp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008077 PECOS PAC ID: 6507766227 Enrollment ID: O20040109000894 |
News Archive
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
The current study found that people were at a slightly higher than normal risk of blood clots after receiving Oxford-AstraZeneca and Pfizer vaccines.
The United Nations Foundation (UN Foundation) announced today that it has received a US$139 million contribution from the GAVI Alliance to support the worldwide effort by the Measles Initiative to reduce measles deaths by 90 percent by 2010.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
Kaiser Health News staff writer Julie Appleby reports on confusion about how the new health law affects college health plans. "Colleges and universities say some rules in the new health law could keep them from offering low-cost, limited benefit student insurance policies
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Jewel Maxine Telleria, MD 2740 South Ave W Ste 101, Missoula, MT 59804-5137 Ph: (406) 728-6101 | Dr Jessica Jewel Maxine Telleria, MD 2740 South Ave W Ste 101, Missoula, MT 59804-5137 Ph: (406) 728-6101 |
News Archive
Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.
The current study found that people were at a slightly higher than normal risk of blood clots after receiving Oxford-AstraZeneca and Pfizer vaccines.
The United Nations Foundation (UN Foundation) announced today that it has received a US$139 million contribution from the GAVI Alliance to support the worldwide effort by the Measles Initiative to reduce measles deaths by 90 percent by 2010.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.
Kaiser Health News staff writer Julie Appleby reports on confusion about how the new health law affects college health plans. "Colleges and universities say some rules in the new health law could keep them from offering low-cost, limited benefit student insurance policies
› Verified 8 days ago
Taylor Buckley, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2740 South Ave W Ste 101, Missoula, MT 59804 Phone: 406-728-6101 Fax: 406-721-3278 | |
Dr. Stephen George Powell, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2831 Fort Missoula Rd, Suite 232, Missoula, MT 59804 Phone: 406-728-6101 Fax: 406-721-3278 | |
Dr. James Joseph Gholson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2360 Mullan Rd Ste C, Missoula, MT 59808 Phone: 406-721-4436 Fax: 406-721-6053 | |
Joseph Fox, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2835 Fort Missoula Rd Ste 201, Missoula, MT 59804 Phone: 406-327-4730 | |
Paul Andrew Puckett, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2360 Mullan Rd, Suite C, Missoula, MT 59808 Phone: 406-721-4436 Fax: 406-721-6053 | |
Dr. Larry R. Stayner, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2740 South Ave W Ste 101, Missoula, MT 59804 Phone: 406-728-6101 Fax: 406-721-3278 | |
Dr. Zackery W Witte, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2360 Mullan Rd Ste C, Missoula, MT 59808 Phone: 406-721-4436 Fax: 406-721-6053 |